Increased Expression of SRSF1 Predicts Poor Prognosis in Multiple Myeloma.
Jiawei ZhangZanzan WangKailai WangDijia XinLuyao WangYili FanYang XuPublished in: Journal of oncology (2023)
The expression value of SRSF1 is positively associated with myeloma progression, and high SRSF1 expression might be a poor prognostic biomarker in MM patients.